Publications by authors named "Beth Zamboni"

Claim this Profile
A
A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia.
Farhad Ravandi, Sravanti Rangaraju, Hagop Kantarjian, Guillermo Garcia-Manero, Musa Yilmaz, Beth A Zamboni, William C Zamboni

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With Cancer.
Li Chen, Andrew T Lucas, Aaron S Mansfield, Stephanie Lheureux, Claire O'Connor, Beth A Zamboni, William C Zamboni

Clin Transl Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction and Technology Acceptance of Staff Regarding Use of Continuous Video Monitoring in Comparison With Sitters.
Abigail Hebb, Michael Kistler, Elisabeth George, Beth Zamboni

J Nurs Adm· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and characteristics associated with surface contamination of hazardous drugs in hospital pharmacies.
Stephanie A Salch, William C Zamboni, Beth A Zamboni, Stephen F Eckel

Am J Health Syst Pharm· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exertional Heat Illness Among Secondary School Athletes: Statewide Policy Implications.
Jill Rodgers, Peggy Slota, Beth Zamboni

J Sch Nurs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors.
Huali Wu, Jeffrey R Infante, Vicki L Keedy, Suzanne F Jones, Emily Chan, Beth A Zamboni, William C Zamboni

Int J Nanomedicine· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer.
Hugh Giovinazzo, Parag Kumar, Arif Sheikh, Kristina M Brooks, Marija Ivanovic, Beth A Zamboni, William C Zamboni

Cancer Chemother Pharmacol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents.
Ryan F Schell, Brian J Sidone, Whitney P Caron, Mark D Walsh, Taylor F White, Beth A Zamboni, William C Zamboni

Nanomedicine· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors.
Huali Wu, Jeffrey R Infante, Vicki L Keedy, Suzanne F Jones, Emily Chan, Beth A Zamboni, William C Zamboni

Eur J Clin Pharmacol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors.
Austin J Combest, Patrick J Roberts, Patrick M Dillon, Katie Sandison, Suzan K Hanna, Beth Zamboni, William C Zamboni

Oncologist· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of study designs and outcomes of phase I clinical studies of nanoparticle agents compared with small-molecule anticancer agents.
Whitney P Caron, Katherine P Morgan, Beth A Zamboni, William C Zamboni

Clin Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.
Huali Wu, Ramesh K Ramanathan, Beth A Zamboni, Sandra Strychor, Suresh Ramalingam, William C Zamboni

Int J Nanomedicine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.
Huali Wu, Ramesh K Ramanathan, Beth A Zamboni, Sandra Strychor, Suresh Ramalingam, William C Zamboni

J Clin Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients.
Ninh M La-Beck, Beth A Zamboni, Alberto Gabizon, Hilary Schmeeda, Michael Amantea, William C Zamboni

Cancer Chemother Pharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer.
William C Zamboni, Austin J Combest, Julie A DeLoia, Robert P Edwards, Arlene S Bridges, Beth A Zamboni

Cancer Chemother Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors.
William C Zamboni, Lauren J Maruca, Sandra Strychor, Beth A Zamboni, Suresh Ramalingam

J Liposome Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models.
William C Zamboni, Julie L Eiseman, Sandra Strychor, Patricia M Rice, Erin Joseph, Beth A Zamboni

J Liposome Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.
Beth A Zamboni, Greg Yothers, Mehee Choi, Clifton D Fuller, James J Dignam

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.
William C Zamboni, Suresh Ramalingam, David M Friedland, Robert P Edwards, Ronald G Stoller, Beth A Zamboni

Clin Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID mice.
William C Zamboni, Laura L Jung, Sandra Strychor, Erin Joseph, Beth A Zamboni

Invest New Drugs· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts.
William C Zamboni, Sandra Strychor, Erin Joseph, Dustin R Walsh, Beth A Zamboni

Clin Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.
Laura P Stabile, Jennifer S Lyker, Stephanie R Land, Sanja Dacic, Beth A Zamboni

Carcinogenesis· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
Sichuan Xi, Kevin F Dyer, Mark Kimak, Qing Zhang, William E Gooding, Beth Zamboni

J Natl Cancer Inst· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors.
Marwan G Fakih, Patrick J Creaven, Nithya Ramnath, Donald Trump, Milind Javle, Beth A Zamboni, William C Zamboni

Clin Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gender gap in a surgical subspecialty: analysis of career and lifestyle factors.
Jennifer Rubin Grandis, William E Gooding, Beth A Zamboni, Marilyn M Wagener, Stephanie D Drenning

Arch Otolaryngol Head Neck Surg· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis